Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 241.50 +4.40 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.10 | 52 Week High | $109.10 | |||
| Open | $235.94 | 52 Week Low | $31.38 | |||
| Day High | $243.02 | P/E | N/A | |||
| Day Low | $233.33 | EPS | $-1.45 | |||
| Volume | 288,086 | |||||
